Search Images Maps Play YouTube News Gmail Drive More »
Advanced Patent Search | Web History | Sign in

Patents

Referenced by

Citing PatentFiling dateIssue dateOriginal AssigneeTitle
US396015015 Sep 19751 Jun 1976Alza CorporationBioerodible ocular device
US396162821 Apr 19758 Jun 1976Alza CorporationOcular drug dispensing system
US39713674 Jun 197527 Jul 1976Alza CorporationIntrauterine device having means for changing from uterine-retentive shape to nonuterine-retentive shape
US398130331 Jul 197521 Sep 1976Alza CorporationBioerodible ocular device
US39865101 Aug 197519 Oct 1976Alza CorporationBioerodible ocular device
US399307124 Jul 197523 Nov 1976Alza CorporationBioerodible ocular device
US39930733 Mar 197523 Nov 1976Alza CorporationNovel drug delivery device
US408374127 Jul 197611 Apr 1978Hoffmann-La Roche, Inc.Novel dosage form
US412650229 Apr 197721 Nov 1978Hoffmann-La Roche Inc.Manufacture of pharmaceutical dosage forms
US412650329 Apr 197721 Nov 1978Hoffmann-La Roche Inc.Manufacture of pharmaceutical dosage forms
US41355149 Mar 197723 Jan 1979Alza CorporationOsmotic releasing system for administering ophthalmic drug to eye of animal
US41425269 Mar 19776 Mar 1979Alza CorporationOsmotic releasing system with means for changing release therefrom
US422814930 May 197814 Oct 1980Beecham Group LimitedSustained release compositions
US43082509 Dec 198029 Dec 1981Beecham Group LimitedSustained drug release device
US443918313 May 198227 Mar 1984ALZA CorporationParenteral agent dispensing equipment
US45212113 Feb 19844 Jun 1985ALZA CorporationParenteral agent dispensing equipment
US454040829 Apr 198210 Sep 1985Smith and Nephew Associated Companies LimitedApplicators for pharmacologically active agents, their preparation and use
US45485983 Feb 198422 Oct 1985ALZA CorporationParenteral agent dispensing equipment
US45766044 Mar 198318 Mar 1986ALZA CorporationOsmotic system with instant drug availability
US46734058 Jan 198616 Jun 1987Alza CorporationOsmotic system with instant drug availability
US469806230 Oct 19856 Oct 1987ALZA CorporationMedical device for pulsatile transdermal delivery of biologically active agents
US488366629 Apr 198728 Nov 1989Massachusetts Institute of TechnologyControlled drug delivery system for treatment of neural disorders
US488687015 Feb 198512 Dec 1989Massachusetts Institute of TechnologyBioerodible articles useful as implants and prostheses having predictable degradation rates
US489122521 Jan 19862 Jan 1990Massachusetts Institute of TechnologyBioerodible polyanhydrides for controlled drug delivery
US490647421 May 19846 Mar 1990Massachusetts Institute of TechnologyBioerodible polyanhydrides for controlled drug delivery
US492741924 Apr 198722 May 1990Agri Research and DevelopmentSustained release medicating device for livestock
US494692915 Jun 19877 Aug 1990Massachusetts Institute of TechnologyBioerodible articles useful as implants and prostheses having predictable degradation rates
US507900613 Jul 19887 Jan 1992Aprex CorporationPharmaceutical compositions containing a magnetically detectable material
US511471914 Sep 198919 May 1992Extended drug delivery of small, water-soluble molecules
US51679628 Aug 19911 Dec 1992Southwest Research InstituteFilament system for delivering a medicament and method
US523673416 Mar 199217 Aug 1993Fuisz Technologies Ltd.Method of preparing a proteinaceous food product containing a melt spun oleaginous matrix
US52386966 May 199224 Aug 1993Fuisz Technologies Ltd.Method of preparing a frozen comestible
US526811027 Aug 19927 Dec 1993Fuisz Technologies Ltd.Oil removing method
US527984912 May 199218 Jan 1994Fuisz Technologies Ltd.Dispersible polydextrose, compositions containing same and method for the preparation thereof
US528651322 Jun 199315 Feb 1994Fuisz Technologies Ltd.Proteinaceous food product containing a melt spun oleaginous matrix
US532656830 Apr 19925 Jul 1994Method of tissue-specific delivery
US534875820 Oct 199220 Sep 1994Fuisz Technologies Ltd.Controlled melting point matrix formed with admixtures of a shearform matrix material and an oleaginous material
US53744476 Dec 199320 Dec 1994Fuisz Technologies Ltd.Method of preparing a reduced-fat meat product
US538047323 Oct 199210 Jan 1995Fuisz Technologies Ltd.Process for making shearform matrix
US53874315 Mar 19927 Feb 1995Fuisz Technologies Ltd.Saccharide-based matrix
US540767624 Dec 199218 Apr 1995Fuisz Technologies Ltd.Hydrophilic form of perfluoro compounds and a method of manufacture
US542780415 Mar 199427 Jun 1995Fuisz Technologies Ltd.Low-fat edible proteins with maltodextrins and low-saturate oils
US542983629 Jul 19934 Jul 1995Fuisz Technologies Ltd.Saccharide-based matrix
US544576927 Jun 199429 Aug 1995Fuisz Technologies Ltd.Spinner head for flash flow processing
US545693222 Apr 199410 Oct 1995Fuisz Technologies Ltd.Method of converting a feedstock to a shearform product and product thereof
US54649356 Feb 19957 Nov 1995Centocor, Inc.Peptide inhibitors of selectin binding
US547273122 Mar 19955 Dec 1995Fuisz Technologies Ltd.Protein based food product
US549099324 Mar 199513 Feb 1996Fuisz Technologies Ltd.Method of preparing a proteinaceous food product containing a melt spun matrix and product thereof
US549467728 Jun 199327 Feb 1996Tissue-specific implantable therapeutic agent delivery system
US550185810 Sep 199326 Mar 1996Fuisz Technologies Ltd.Rapidly dispersable compositions containing polydextrose
US550386226 May 19952 Apr 1996Fuisz Technologies Ltd.Method of subjecting a protein-containing material to flash flow processing and product thereof
US551653721 Feb 199514 May 1996Fuisz Technologies Ltd.Frozen comestibles
US551855110 Sep 199321 May 1996Fuisz Technologies Ltd.Spheroidal crystal sugar and method of making
US55187303 Jun 199221 May 1996Fuisz Technologies Ltd.Biodegradable controlled release flash flow melt-spun delivery system
US55208598 Apr 199428 May 1996Fuisz Technologies Ltd.Method for flash flow processing having feed rate control
US55454095 Apr 199413 Aug 1996Massachusetts Institute of TechnologyDelivery system for controlled release of bioactive factors
US55499177 Jun 199527 Aug 1996Fuisz Technologies Ltd.Flash flow formed solloid delivery systems
US55566525 Aug 199417 Sep 1996Fuisz Technologies Ltd.Comestibles containing stabilized highly odorous flavor component delivery systems
US55674394 Nov 199422 Oct 1996Fuisz Technologies Ltd.Delivery of controlled-release systems(s)
US55760422 Mar 199419 Nov 1996Fuisz Technologies Ltd.High intensity particulate polysaccharide based liquids
US55828551 Jul 199410 Dec 1996Fuisz Technologies Ltd.Flash flow formed solloid delivery systems
US558719831 May 199524 Dec 1996Fuisz Technologies Ltd.Positive hydration method of preparing confectionery and product therefrom
US55935026 Jun 199514 Jan 1997Fuisz Technologies Ltd.Method of making crystalline sugar and products resulting therefrom
US55974167 Oct 199328 Jan 1997Fuisz Technologies Ltd.Method of making crystalline sugar and products resulting therefrom
US559760828 Dec 199428 Jan 1997Fuisz Technologies Ltd.Saccharide-based matrix incorporating maltodextrin and process for making
US56010765 Jun 199511 Feb 1997Fuisz Technologies Ltd.Spheroidal crystal sugar and method of making
US560183512 Jan 199411 Feb 1997Massachusetts Institute of TechnologyPolymeric device for controlled drug delivery to the CNS
US560223010 May 199511 Feb 1997Centocor, Inc.Peptide inhibitors of selectin binding
US56187851 Jun 19958 Apr 1997Centocor, Inc.Peptide inhibitors of selectin binding
US562271923 May 199622 Apr 1997Fuisz Technologies Ltd.Process and apparatus for making rapidly dissolving dosage units and product therefrom
US562468417 Nov 199329 Apr 1997Fuisz Technologies Ltd.Enzyme systems
US56290097 Aug 199613 May 1997Massachusetts Institute of TechnologyDelivery system for controlled release of bioactive factors
US56330277 Jun 199527 May 1997Fuisz Technologies Ltd.Confectioneries containing stabilized highly odorous flavor component delivery systems
US565198727 Aug 199329 Jul 1997Fuisz Technologies Ltd.Ulcer prevention and treatment composition
US565400310 Feb 19945 Aug 1997Fuisz Technologies Ltd.Process and apparatus for making tablets and tablets made therefrom
US565427322 Sep 19945 Aug 1997Children's Medical Center CorporationSynducin mediated modulation of tissue repair
US56608482 Nov 199426 Aug 1997The Population Council, Center for Biomedical ResearchSubdermally implantable device
US56608515 Jun 199526 Aug 1997Yissum Research Development Company of the Hebrew Univ. of JerusalemOcular inserts
US57098767 Jun 199520 Jan 1998Fuisz Technologies Ltd.Saccharide-based matrix
US57101239 Jun 199520 Jan 1998Centocor, Inc.Peptide inhibitors of selectin binding
US57138527 Jun 19953 Feb 1998Alza CorporationOral dosage and method for treating painful conditions of the oral cavity
US57283974 Feb 199717 Mar 1998Fuisz Technologies Ltd.Polydextrose product and process
US573357716 Aug 199631 Mar 1998Fuisz Technologies Ltd.Delivery of controlled-release system (s)
US574418023 Oct 199628 Apr 1998Fuisz Technologies Ltd.Comestibles containing stabilized highly odorous flavor component delivery systems
US57536177 Mar 199519 May 1998Centocor, Inc.Peptide inhibitors of cellular adhesion
US57561157 Jun 199526 May 1998The Population Coucil, Center for Biomedical ResearchContraceptive method using a subdermally implantable device
US57595396 Jun 19952 Jun 1998Georgia Research Foundation, Inc.Method for rapid enzymatic alcohol removal
US580424720 Dec 19968 Sep 1998Fuisz Technologies Ltd.Positive hydration method of preparing confectionary and product therefrom
US58243429 Apr 199620 Oct 1998Fuisz Technologies Ltd.Flash flow formed solloid delivery systems
US582756313 Jan 199727 Oct 1998Fuisz Technologies Ltd.Spheroidal crystal sugar
US584388415 Nov 19951 Dec 1998Oklahoma Medical Research FoundationC9 complement inhibitor
US584392211 Jun 19961 Dec 1998Fuisz Technologies Ltd.Preparation of oligosaccharides and products therefrom
US584990028 Mar 199515 Dec 1998Max-Planck-Gesellschaft zur Forderung der Wissenschafter e.v.Inhibition of viruses by antisense oligomers capable of binding to polypurine rich tract of single-stranded RNA or RNA-DNA hybrids
US585155216 Aug 199622 Dec 1998Fuisz Technologies, Ltd.Delivery of controlled-release system(s)
US585155319 Dec 199622 Dec 1998Fuisz Technologies, Ltd.Process and apparatus for making rapidly dissolving dosage units and product therefrom
US58537602 Dec 199429 Dec 1998LTS Lohmann Therapie-Systeme GmbH & Co. KGDevice for the controlled release of active substances
US585376216 Aug 199629 Dec 1998Fuisz Technologies LtdDelivery of controlled-release system(s)
US585838521 Jul 199712 Jan 1999The Trustees of the Stevens Institute of TechnologyControlled release device and method based on aqueous--organic partitioning in porous membranes
US585922720 Feb 199712 Jan 1999Bearsden Bio, Inc.RNA sequences which interact with RNA-binding proteins
US586616319 Dec 19962 Feb 1999Fuisz Technologies Ltd.Process and apparatus for making rapidly dissolving dosage units and product therefrom
US587178119 Dec 199616 Feb 1999Fuisz Technologies Ltd.Apparatus for making rapidly-dissolving dosage units
US588898231 Mar 199730 Mar 1999President and Fellows of Harvard CollegeRegulation of vascular smooth muscle cell heme oxygenase-1
US589566414 Jun 199420 Apr 1999Fuisz Technologies Ltd.Process for forming quickly dispersing comestible unit and product therefrom
US589806626 Aug 199427 Apr 1999Children's Medical Center CorporationTrophic factors for central nervous system regeneration
US591687622 Dec 199429 Jun 1999Centocor, Inc.Peptide inhibitors of leukocyte adhesion
US592533315 Nov 199520 Jul 1999Massachusetts Institute of Technology
Board of Regents, The University of Texas System
Methods for modulation of lipid uptake
US596232215 Nov 19965 Oct 1999Massachusetts Institute of Technology
The Trustees of the University of Pennsylvania
Methods for modulation of cholesterol transport
US60019907 Jun 199514 Dec 1999The General Hospital CorporationAntisense inhibition of hepatitis C virus
US600474931 Jul 199721 Dec 1999Message PharmaceuticalsMethod for identifying compounds affecting RNA/RNA binding protein interactions
US60200025 Nov 19971 Feb 2000Fuisz Technologies Ltd.Delivery of controlled-release system(s)
US603410131 Jul 19977 Mar 2000ALZA CorporationDosage form and method for administering drug
US610702931 Jul 199622 Aug 2000Message Pharmaceticals, Inc.Universal method for detecting interactions between RNA molecules and RNA binding proteins
US61104814 Mar 199429 Aug 2000Trustees of the Stevens Institute of TechnologyControlled release device based on aqueous-organic partitioning in porous membranes
US612426720 Apr 199826 Sep 2000Southpac Trust Internationals, Inc.O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US612992629 Oct 199310 Oct 2000Fuisz Technologies Ltd.Flash flow processing of thermoplastic polymers and products made therefrom
US619699319 Apr 19996 Mar 2001Eyelab Group, LLCOphthalmic insert and method for sustained release of medication to the eye
US62007517 Nov 199713 Mar 2001Oklahoma Medical Research FoundationEndothelial specific expression regulated by EPCR control elements
US62038139 Oct 199820 Mar 2001Pharmaceutical delivery device and method of preparation therefor
US62847296 May 19984 Sep 2001Children's Medical Center CorporationMethods and reagents for regulating obesity
US62998754 Jun 19989 Oct 2001Panacea Pharmaceuticals, LLCMethods to block IGE binding to cell surface receptors of mast cells
US630642813 Apr 199823 Oct 2001Roehm GmbH Chemische FabrikTime-release laminar pharmaceutical composition
US63096399 Aug 200030 Oct 2001The Board of Regents of the University of OklahomaMethod for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US63508592 Feb 199926 Feb 2002Massachusetts Institute of TechnologyClass BI and CI scavenger receptors
US639906429 Oct 19984 Jun 2002Oklahoma Medical Research FoundationCloning and regulation of an endothelial cell protein C/activated protein C receptor
US640723623 Aug 199918 Jun 2002Medco Research, Inc.Adenosine A3 receptor modulators
US64105087 Oct 199925 Jun 2002Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
US644825316 Sep 199810 Sep 2002King Pharmaceuticals Research and Development, Inc.Adenosine A3 receptor modulators
US650638229 Oct 200114 Jan 2003The Board of Regents of the University of OklahomaMethod for inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand
US666703618 Nov 200223 Dec 2003The Board of Regents of the University of OklahomaMethods of treatment using antibodies to P-selectin glycoprotein ligand
US691937319 Feb 199919 Jul 2005Alza CorporationMethods and devices for providing prolonged drug therapy
US692182526 Apr 200226 Jul 2005King Pharmaceuticuals Research & Development, Inc.Adenosine A3 receptor modulators
US69301298 Mar 200116 Aug 2005Alza CorporationMethods and devices for providing prolonged drug therapy
US695356825 Aug 199811 Oct 2005Oklahoma Medical Research FoundationTargeting of molecules to large vessel endothelium using EPCR
US704535029 Aug 200216 May 2006Mount Sinai School of Medicine of New York UniversityAlternatively spliced circulating tissue factor
US706384320 Aug 199920 Jun 2006Oklahoma Medical Research FoundationCloning and regulation of an endothelial cell protein C/activated protein C receptor
US707851119 Jun 199518 Jul 2006Massachusette Institute of TechnologyClass BI and CI scavenger receptors
US71665689 Feb 199823 Jan 2007Oklahoma Medical Research FoundationCompositions and methods to inhibit formation of the C5b-9 complex of complement
US72084677 Jun 200224 Apr 2007Lipid-altering compositions for the treatment of infertility
US724145729 Sep 200410 Jul 2007Alza CorporationOsmotically driven active agent delivery device providing an ascending release profile
US730658016 Apr 200311 Dec 2007Cook IncorporatedMedical device with therapeutic agents
US730658016 Apr 200311 Dec 2007Cook IncorporatedMedical device with therapeutic agents
US736168416 May 200222 Apr 2008Massachusetts Institute of TechnologyScreening of compounds for treatment of atherosclerosis and heart attack
US75145925 Apr 20057 Apr 2009Massachusetts Institute of TechnologyInducible heart attack animal model
US778064731 Oct 200724 Aug 2010Cook IncorporatedMedical device with therapeutic agents
US778563215 Sep 200431 Aug 2010Ordway Research Institute, Inc.
Albany College of Pharmacy
Thyroid hormone analogs and methods of use
US77860901 Mar 200731 Aug 2010President and Fellows of Harvard CollegeMethods and compositions for treating and preventing neurologic disorders
US782470415 Aug 20052 Nov 2010Surmodics, Inc.Controlled release bioactive agent delivery device
US796060619 Jun 200714 Jun 2011The J. David Gladstone Institutes
The Regents of the University of California
The United States of America as represented by the Department of Veterans Affairs
Mouse model of chronic heart failure and coronary atherosclerosis regression
US797686215 Aug 200512 Jul 2011Surmodics, Inc.Controlled release bioactive agent delivery device
US802168029 Apr 200420 Sep 2011Surmodics, Inc.Controlled release bioactive agent delivery device
US803436912 Sep 200511 Oct 2011Surmodics, Inc.Controlled release bioactive agent delivery device
US807113415 Sep 20056 Dec 2011Ordway Research Institute, Inc.
Albany College of Pharmacy
Thyroid hormone analogs and methods of use
US808405915 Sep 200627 Dec 2011ALZA CorporationAntidepressant dosage form
US816379812 Aug 200324 Apr 2012Alza CorporationMethods and devices for providing prolonged drug therapy
US82114014 Dec 20093 Jul 2012Molecular Insight Pharmaceuticals, Inc.Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
US82114024 Dec 20093 Jul 2012Molecular Insight Pharmaceuticals, Inc.CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
US823504730 Mar 20067 Aug 2012Conceptus, Inc.Methods and devices for deployment into a lumen

Drawings